CD44 and neoplasm: In a murine xenograft model, Fap1 inhibition was associated with decreased tumor growth, delayed progression after oxaliplatin, decreased relative abundance of CD133+CD44+ cells, and phosphorylation of Fap1 substrates (Fas and Gsk3β).